spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Lyase PDB id
2nmp
Jmol
Contents
Protein chains
376 a.a. *
Ligands
PLP ×3
Waters ×157
* Residue conservation analysis
PDB id:
2nmp
Name: Lyase
Title: Crystal structure of human cystathionine gamma lyase
Structure: Cystathionine gamma-lyase. Chain: a, b, c, d. Fragment: residues 1-402. Synonym: gamma-cystathionase. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: cth. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
Biol. unit: Tetramer (from PQS)
Resolution:
2.60Å     R-factor:   0.180     R-free:   0.245
Authors: T.Karlberg,J.Uppenberg,C.Arrowsmith,H.Berglund,R.D.Busam,R.C A.Edwards,U.B.Ericsson,S.Flodin,A.Flores,S.Graslund,B.M.Hal M.Hammarstrom,M.Hogbom,I.Johansson,T.Kotenyova,A.Magnusdott M.Moche,M.E.Nilsson,P.Nordlund,T.Nyman,D.Ogg,C.Persson,J.Sa P.Stenmark,M.Sundstrom,A.G.Thorsell,S.Van-Den-Berg,K.Wallde J.Weigelt,L.Holmberg-Schiavone,Structural Genomics Consorti
Key ref:
Q.Sun et al. (2009). Structural basis for the inhibition mechanism of human cystathionine gamma-lyase, an enzyme responsible for the production of H(2)S. J Biol Chem, 284, 3076-3085. PubMed id: 19019829 DOI: 10.1074/jbc.M805459200
Date:
23-Oct-06     Release date:   07-Nov-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P32929  (CGL_HUMAN) -  Cystathionine gamma-lyase
Seq:
Struc:
405 a.a.
376 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.4.4.1.1  - Cystathionine gamma-lyase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-cystathionine + H2O = L-cysteine + NH3 + 2-oxobutanoate
L-cystathionine
+ H(2)O
= L-cysteine
+ NH(3)
+ 2-oxobutanoate
      Cofactor: Pyridoxal 5'-phosphate
Pyridoxal 5'-phosphate
Bound ligand (Het Group name = PLP) matches with 93.75% similarity
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     cytoplasm   2 terms 
  Biological process     metabolic process   12 terms 
  Biochemical function     catalytic activity     6 terms  

 

 
    reference    
 
 
DOI no: 10.1074/jbc.M805459200 J Biol Chem 284:3076-3085 (2009)
PubMed id: 19019829  
 
 
Structural basis for the inhibition mechanism of human cystathionine gamma-lyase, an enzyme responsible for the production of H(2)S.
Q.Sun, R.Collins, S.Huang, L.Holmberg-Schiavone, G.S.Anand, C.H.Tan, S.van-den-Berg, L.W.Deng, P.K.Moore, T.Karlberg, J.Sivaraman.
 
  ABSTRACT  
 
Impairment of the formation or action of hydrogen sulfide (H(2)S), an endogenous gasotransmitter, is associated with various diseases, such as hypertension, diabetes mellitus, septic and hemorrhagic shock, and pancreatitis. Cystathionine beta-synthase and cystathionine gamma-lyase (CSE) are two pyridoxal-5'-phosphate (PLP)-dependent enzymes largely responsible for the production of H(2)S in mammals. Inhibition of CSE by DL-propargylglycine (PAG) has been shown to alleviate disease symptoms. Here we report crystal structures of human CSE (hCSE), in apo form, and in complex with PLP and PLP.PAG. Structural characterization, combined with biophysical and biochemical studies, provides new insights into the inhibition mechanism of hCSE-mediated production of H(2)S. Transition from the open form of apo-hCSE to the closed PLP-bound form reveals large conformational changes hitherto not reported. In addition, PAG binds hCSE via a unique binding mode, not observed in PAG-enzyme complexes previously. The interaction of PAG-hCSE was not predicted based on existing information from known PAG complexes. The structure of hCSE.PLP.PAG complex highlights the particular importance of Tyr(114) in hCSE and the mechanism of PAG-dependent inhibition of hCSE. These results provide significant insights, which will facilitate the structure-based design of novel inhibitors of hCSE to aid in the development of therapies for diseases involving disorders of sulfur metabolism.
 
  Selected figure(s)  
 
Figure 1.
Crystal structure of hCSE. a, ribbon diagram of the hCSE monomer. N and C termini are labeled. The large PLP binding domain is shown in red, the small domain in green, and PLP in yellow. Panels b and c are the superimposed apo-hCSE (blue) and PLP complex (red) active site regions. The Met^110–Asn^118 region (b) and loop Thr^211–Met^214 (c) are shown. The root mean square deviation between two superimposed models is 1.5 Å for 336 Cα atoms. PLP, Tyr^114, and Lys^212 are shown in stick representations. d, stereoview of the 2F[o] - F[c] simulated annealing omit map of PLP from hCSE·PLP. All atoms within 3.5 Å of PLP were omitted prior to refinement. The map was contoured at a level of 1.0σ. These figures were prepared using the program PyMol (32). Shown is the electrostatic surface potential at the active site region of apo-hCSE (e) and hCSE·PLP (f). Apo-hCSE shows significant enlarged (open) surface. These figures were prepared using the program GRASP (33).
Figure 5.
Mechanism of PAG inhibition on hCSE. Upon the addition of the inhibitor, the α-amino group of PAG is first deprotonated by Arg^62 of the adjacent monomer (B:) (Step 1) for transaldimination to occur (Step 2). Lys^212 then abstracts a proton from the β-position of the bound alkyne to generate an activated allene (Step 3), which is then attacked by the hydroxyl group of Tyr^114 (Step 4) to produce a vinyl ether. Subsequent transaldimination with Lys^212 (Step 5) regenerates the internal aldimine.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2009, 284, 3076-3085) copyright 2009.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19769466 D.R.Linden, M.D.Levitt, G.Farrugia, and J.H.Szurszewski (2010).
Endogenous production of H2S in the gastrointestinal tract: still in search of a physiologic function.
  Antioxid Redox Signal, 12, 1135-1146.  
19654230 A.F.Perna, M.G.Luciano, D.Ingrosso, P.Pulzella, I.Sepe, D.Lanza, E.Violetti, R.Capasso, C.Lombardi, and N.G.De Santo (2009).
Hydrogen sulphide-generating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes.
  Nephrol Dial Transplant, 24, 3756-3763.  
19486912 L.Li, A.Hsu, and P.K.Moore (2009).
Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation--a tale of three gases!
  Pharmacol Ther, 123, 386-400.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.